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Advances in mapping malaria 
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falciparum incidence
Victor A. Alegana1,2, Peter M. Atkinson1,3,4, Christopher Lourenço1,5, Nick W. Ruktanonchai1,2, 
Claudio Bosco1,2, Elisabeth zu Erbach-Schoenberg1,2, Bradley Didier5, Deepa Pindolia5, 
Arnaud Le Menach5, Stark Katokele6, Petrina Uusiku6 & Andrew J. Tatem1,2
The long-term goal of the global effort to tackle malaria is national and regional elimination and 
eventually eradication. Fine scale multi-temporal mapping in low malaria transmission settings remains 
a challenge and the World Health Organisation propose use of surveillance in elimination settings. 
Here, we show how malaria incidence can be modelled at a fine spatial and temporal resolution from 
health facility data to help focus surveillance and control to population not attending health facilities. 
Using Namibia as a case study, we predicted the incidence of malaria, via a Bayesian spatio-temporal 
model, at a fine spatial resolution from parasitologically confirmed malaria cases and incorporated 
metrics on healthcare use as well as measures of uncertainty associated with incidence predictions. 
We then combined the incidence estimates with population maps to estimate clinical burdens and 
show the benefits of such mapping to identifying areas and seasons that can be targeted for improved 
surveillance and interventions. Fine spatial resolution maps produced using this approach were then 
used to target resources to specific local populations, and to specific months of the season. This remote 
targeting can be especially effective where the population distribution is sparse and further surveillance 
can be limited to specific local areas.
An increasing number of countries at the margins of the endemic range of malaria are moving towards elimina-
tion of the disease1–3. As countries transition to controlled low-endemic malaria transmission settings, challenges 
arise in terms of how the disease burden is quantified and how to produce robust operational malaria cartogra-
phy to guide control and elimination strategies4–6. A primary reason for this is that the disease tends to cluster 
in hotspots and is also hard to detect parasites at low levels of transmission in the general population using the 
current diagnostic methods7. The traditional snapshot prevalence surveys are not suitable for tracking changes 
in burden in low malaria transmission, because malaria cases are usually sporadic, susceptible to changes in cli-
mate, ecology, population movements or intervention coverages8,9. As countries in the malaria pre-elimination 
phase focus on improvement of surveillance and health information systems10,11, the measurement of incidence 
(rather than prevalence) based on passive and active surveillance represents a cheaper (compared to investing in 
active surveys) and potentially important evidence base for mapping transmission, to facilitate the targeting of 
interventions12,13.
Using passive surveillance data for mapping malaria requires that health facility cases are parasitologically 
confirmed via rapid diagnostic tests (RDTs) or microscopy and are complete both spatially and temporally14. 
However, these data are usually incomplete14, and thus, approaches are required that adjust for health facility 
utilisation and under-reporting15–18. Although incidence coupled with information on health care access has 
been mapped at a coarse resolution in low malaria transmission settings17,18, there is no robust quantification 
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of incidence at fine spatial resolution from passive surveillance data to guide malaria programmes in controlled 
low-endemic transmission settings. Where malaria has been eliminated recently, for example, in Turkmenistan, 
Reunion Island, Mauritius and Tunisia, the elimination programmes relied on the simplified mapping of cases 
or hand drawn maps (see WHO elimination case studies19). These were difficult to produce logistically and 
update rapidly, were not consistent across large areas and did not benefit from the kind of geographic informa-
tion system (GIS) integration with population maps20 that is available today to estimate burden for planning or 
effective resource allocation during elimination efforts. Other previous attempts at quantifying malaria risk in 
low-endemic malaria transmission areas have used ecological niche modelling approaches using presence and 
absence of malaria cases to predict probability of a case21 or using regression tree methods22,23. Incidence was not 
estimated directly using these approaches, which also did not incorporate the spatial and temporal dependencies 
in the data, or measures of uncertainty associated with predictions24.
Here, we propose a flexible modelling framework for fine spatial and temporal mapping of P. falciparum 
malaria incidence in elimination settings. A bivariate model specification based on cases aggregated at district 
level was used to inform predictions of incidence at fine spatial resolution and across multiple time periods. 
The main goal was the prediction of a time-series of monthly malaria incidence at a fine spatial resolution with 
complete coverage based on incidence measured at health facilities (i.e., representing a facility catchment, with 
the equivalent of a coarse spatial resolution), supported by fine resolution remotely sensed spatio-temporal 
covariates, and incorporating uncertainty. The fine spatial resolution prediction should help pre-elimination pro-
grammes to allocate resources effectively to the population most in need, maximising public health impact.
Overview of analytical framework for mapping of malaria incidence at fine spatial 
resolution
A framework for mapping malaria incidence at a fine spatial resolution in low transmission settings is presented 
here (Figs 1 and 2) and technical details are provided in the methods section. Mapping malaria in low trans-
mission settings is a challenge, since as incidence drops, transmission concentrates in hot spots and “hotpops” 
Figure 1. Generalised mapping of fine scale P. falciparum incidence in low transmission settings.  
(A) Shows an example landscape. Certain areas such as swamps are breeding sites for anopheles mosquitoes 
that sustain malaria transmission resulting in focal transmission areas (hotspot with infected houses). Often 
hotspots are located in areas far from health facilities. (B) The probability of seeking treatment at health 
facilities by population located far from health facility catchment area reduces with distance in addition to 
other socio-demographic factors. With infected people generally having low immunity in a low-endemic 
malaria transmission settings, fever onset is likely to be rapid once infected, leading to presentation at health 
facilities. However some can be missed, such as the house in the lower right corner. (C) Assembled cases over 
time at facilities combined with remotely sensed data from satellites (vegetation) showing potential risk areas. 
The vegetation index map was obtained from Moderate Resolution Imaging Spectrometer (MODIS) satellite 
imagery (http://modis.gsfc.nasa.gov/) and map created in ESRI ArcGIS 10.2 software (http://www.esri.com/
software/arcgis/). Satellite data cover large geographic areas and are useful in predicting risk in areas with no 
sampled data. (D) Mapping from health facility data coupled with environmental covariates leads to a gridded 
fine spatial resolution map of predicted incidence for each month, highlighting only populated areas (coloured 
squares) that can be targeted for interventions and active surveillance.
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(populations that maintain malaria transmission)25 (Fig. 1b). It is challenging to identify hotpops operationally 
because only a subset of febrile individuals may seek treatment at formal (health facilities) and informal (drug 
shops and drug vendors) centres26. As shown in Fig. 2, some mild fever cases, representing a proportion of people 
infected may self-resolve26,27. In low malaria transmission settings, immune status plays an important role in 
treatment seeking patterns8. For instance, the onset of fever in low-immunity populations may lead to presenta-
tion at peripheral health centres, while populations highly exposed (hotpops) are less likely to seek treatment28. 
The presenting fevers must be confirmed via parasitology for effective case management before treatment based 
on guidelines from WHO T3 (test-treat-track)29. Current evidence suggests an increasing use of diagnostics in 
health facilities under this initiative30.
Data from health facilities provide a means of detecting hotspots of transmission (Figs 1 and 2 for cases 
presenting at health facilities)31,32. These data have the advantages of being reported on a continuous basis at a 
national level providing a temporal signal that captures the seasonal variability of malaria in low transmission set-
tings33. For example, cases seen at a health facility can be aggregated by month and used to produce monthly maps 
of malaria incidence. However, some febrile cases outside health facility catchments may be missed as shown in 
Fig. 1(c). Thus, using health facility data for mapping malaria incidence requires an adjustment for healthcare use, 
both in the public and private sectors34,35. At a national level, such information can be obtained from geo-located 
nationally representative household surveys such as the Demographic and Health Surveys (DHS) or Malaria 
Indicator Surveys (MIS)16,36. Quantifying the probability of health facility use in both public and private health 
facilities (for example, Fig. 1c) is potentially beneficial in identifying the population not covered by health care 
systems. Estimating the probability of health facility use combines the behavioural aspect of fever treatment for 
malaria from household surveys and distance or travel times to a health facility modelled using landscape char-
acteristics such as land cover, urbanisation and elevation16,37. Although an assumption can be made for treatment 
seeking behaviour to nearest facility based on distance38,39, this should be evaluated in different transmission set-
tings40. Distance-decay curves are then modelled based on the logistic regression between the binary outcome of 
fever treatment from household survey and travel times37. Probability of use is estimated based on the regression 
parameters and used as an adjustment to population seen at peripheral health facilities16.
The final phase uses Bayesian modelling techniques combined with environmental variables (predictors) that 
support transmission and malaria case numbers (Fig. 1(c)) to produce a gridded fine spatial resolution map of 
malaria incidence (Fig. 1(d)). Technical details of Bayesian modelling framework used in this study are pro-
vided in the methods section. In general, both static (only spatial) and space-time covariates can be assembled. 
Advances in satellite remote sensing enable assembly of both climatic (rainfall) and ecological (vegetation) covari-
ates that can be matched with case data from health facilities. These support prediction of incidence at unsampled 
locations with matching environmental conditions21,41,42. The Bayesian inference method harnesses the spatial 
and temporal dependencies (covariance) in the observed malaria cases and their relations with environmental 
predictors while incorporating measures of uncertainty into the output maps of incidence. The generalised linear 
mixed class of models are used to connect observed data to environmental predictors, making use of spatial and 
temporal covariances, and incorporating a random error, since the model is never perfect24. The combination of 
the model parameters relating to covariates, model intercept, spatial and temporal covariance, random effects or 
Figure 2. Generalised schematic representation of data flow and analysis for prediction of incidence. 
Technical details of the modelling framework at prediction stage are provided in the methods section.
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noise and prior information about the disease builds a model used for computation. The computational model-
ling is checked via a validation subset data and by comparing the mean predictions (Fig. 2) from modelling to the 
observed data. In practice, other goodness of fit statistics such as deviance are also estimated43. Uncertainty in the 
model may relate to error sources and affect confidence interval estimates on incidence. These stem from uncer-
tainties observed in case data, environmental variables affecting malaria transmission, health care utilisation and 
in the Bayesian modelling parameters related to prediction. The confidence interval estimates associated with 
incidence predictions may be useful in planning and directing resources to populations as well as guiding future 
surveys to reduce uncertainties in estimates. Incidence estimates are then combined with population maps20 to 
estimate populations at risk at any level (last stage in Fig. 2). At district level, these can be used to categorize high, 
medium, and low transmission districts for operational and planning purposes. The intersection of a population 
map with the incidence map may also show “hotpops” that can be targeted for surveillance which may unearth 
asymptomatic infections.
Case study: Mapping seasonal P. falciparum incidence in Namibia. The modelling framework out-
lined above was demonstrated in an application to northern Namibia to produce continuous spatial and temporal 
predictions of P. falciparum malaria incidence at 1 × 1 km spatial resolution. Namibia’s current malaria strategy 
aims to achieve a national case incidence of less than 1.0 per 1000 population by 201744. Assessing the burden of 
malaria is useful in guiding future surveillance and targeting of malaria interventions. Transmission occurs in the 
endemic northern regions, considered to contribute almost the entire malaria burden in Namibia44,45. Therefore, 
the case study here was restricted to these regions (Fig. 1 in supplementary information).
P. falciparum case data, from both public (90.1%) and private (9.9%) health facilities, were obtained from 
the Namibia National Vector-borne Diseases Control Programme (NVDCP) for 29 months from January 2012 
to May 2014 (supplementary information). Healthcare utilisation in Namibia was estimated from the proba-
bility of health facility attendance for fever treatment described elsewhere16. In brief, travel times were calcu-
lated between health facilities and clusters from a national representative survey (the Malaria Indicator Survey 
(MIS)) and used to derive a distance-decay curve characterizing utilization of health facilities with journey times. 
Several factors were considered while deriving the travel times including different modes of travel (motorised 
and non-motorised), land use and land cover characteristics, and type of road. Travel speeds were assigned sep-
arately to these factors. The probability of health facility attendance for fever treatment was then modelled using 
logistic regression based on assumption of using the nearest health facility. The output gridded probability map 
(similar to Fig. 1b) was combined with a gridded population map and a regional facility reporting rate to derive 
a population-weighted surface of health facility attendance to provide the denominator in modelling incidence 
(Fig. 2). The gridded population map was obtained from an online population mapping database (WorldPop20) at 
100 m spatial resolution and projected forward to 2012, 2013 and 2014 using United Nations national population 
growth estimates for each year46. Modelling incorporated precipitation and vegetation covariates that matched the 
malaria case data in space and time (dates) (supplementary information for a complete description of covariates). 
These included monthly precipitation estimates from the Tropical Applications of Meteorology using Satellite 
data (TAMSAT) and ground based observations47 and vegetation index (enhanced vegetation index (EVI)) from 
the Terra-Moderate Resolution Imaging Spectroradiometer (MODIS) sensor48. These covariates were standard-
ized prior to analysis by centering on the mean and dividing by the standard deviation.
The outputs were fine spatial resolution monthly maps of estimated P. falciparum incidence in northern 
Namibia. The data and spatially matched covariates were used in a Bayesian model to produce continuous maps 
of incidence in each 1 × 1 km grid square in northern Namibia. The Bayesian framework used a linear com-
bination of covariates, malaria cases, and included spatial and temporal effects at the computation stage (see 
full model parameter specification in supplementary information). In applying the modelling framework, health 
facility data were aggregated to the district level while uncertainty maps were produced with predictions at a fine 
spatial resolution. Missing data points were treated as ‘NA’ predicted by the model. Model goodness-of-fit was 
checked using the deviance information criterion (DIC) and marginal likelihood. A Pearson correlation was used 
to compare the predictions to observed data using a 20% (n = 70 health facilities) validation sample. Other model 
parameters including the spatial variance, and spatial range were estimated. The predicted incidence estimates 
were then categorised into three zones of low, medium and high priority districts for operational and planning 
purposes. The population living in different risk categories was also estimated by extracting total counts after 
reclassification.
Results
The predicted malaria incidence and the clinical burden. P. falciparum malaria incidence in northern 
Namibia exhibited strong seasonality, and Fig. 3 maps the predicted incidence on a 1 × 1 km grid by month, while 
Fig. 4(a) shows the variation in predicted incidence at the district level. Figure 4(b) shows a scatterplot with 95% 
credible interval estimates of population at risk at the district level, while Fig. 4(c) displays the estimated popula-
tion at risk at the district level by month. The incidence of P. falciparum peaked in January and February and was 
lowest between May and October, with the greatest risk in regions bordering Angola and Zambia in Zambezi, 
Ohangwena and Kavango. The mean predicted incidence per 1000 population in Zambezi was 3.19 [95% Crl 
2.90–3.77] in January and 3.00 [2.91–3.89] in February; and 2.70 [2.50–2.99] in January and, 2.70 [2.51–3.00] 
in February for Kavango. The mean predicted incidence at a fine spatial resolution for the entire period of data 
was < 1.0 per 1000 population for the majority of the northern regions in Namibia except for Ohangwena region 
where it was 1.13 [0.26–1.89]. At the 1 × 1 km grid square level, the mean predicted incidence for the entire 
northern region was 0.86 [0.29–1.45] compared to a crude (non-modelled) incidence estimate of 4.6 cases per 
1000 population.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:29628 | DOI: 10.1038/srep29628
Table 1 shows the estimated case burden by region. Based on the modelled mean incidence for the 29 month 
period, the majority of the population lived in areas with less than 1.0 case per 1000 population (Table 1). An 
estimated 76.1% of the population resided in areas with an incidence of 0.5 to 1.0 per 1000 population compared 
to 17.7% in areas with less than 0.5 cases per 1000 population. Finally, 6.2% lived in regions where mean incidence 
was estimated to be > 1.0 per 1000 population, mainly in Zambezi and Kavango. The two regions combined con-
stitute approximately 18% of the population of northern Namibia (Table 1).
For operational purposes, the Namibia NVDCP has already used the output maps of malaria incidence pre-
sented here in stratifying and deciding on appropriate response according to operational strata. In terms of strati-
fication, the highest risk was in districts in Zambezi (Katima, Andara,), Okavango (Nyangana, Rundu, Nankudu) 
and one district in Ohangwena (Kongo). These districts were categorised as zone 1 districts, requiring con-
certed effort to reduce malaria incidence to less than 1 case per 1000 population. Zone 2 districts (Groofontein, 
Okakerara, Otjiwarongo, Tsumed, Onadjokwe, Eenhana, Engela, Oshikuku and Outapi) and zone 3 districts 
(Gobabis, Opuwo, Khorixas, Outjo, Okahao, Oshakati and Tsandi) should be targeted for elimination starting 
preferably with any focal transmission areas in these districts. A map showing these priority districts is included 
in the supplementary information.
Table 2 lists the estimated parameters of the fitted bivariate spatio-temporal model for incidence. In terms 
of prediction at a fine spatial resolution, the space-time covariates were significant predictors compared to the 
district level aggregate covariate (precipitation). Although the impact of rainfall on Anopheles mosquitoes is well 
studied49,50, this direct effect was not assessed here. The correlation parameter, related to the cross-spatial covar-
iance model specification, was close to one. The posterior mean of the variance of the spatial process at pixel 
level was 0.31 (95% credible interval 0.28–0.36) while the posterior mean of the noise parameter was 1.45 (1.41–
1.49) suggesting that the latter (residual component) explained more of the variation in incidence. The model 
was improved by including mean rainfall estimates at the district level (DIC 43610.76, marginal log-likelihood 
− 38114.92, model complexity 123.24) compared to when excluded (DIC 43820.90, marginal log-likelihood − 
38170.38, model complexity 117.05). This suggested a justification for using the covariate (mean rainfall esti-
mates) at the district level. Model parameters were also more precisely estimated when spatial covariance that 
model spatial dependencies in the data were included (DIC 47558.99, marginal log-likelihood − 23911.46, model 
complexity 34.14 by excluding spatial effects). The mean square error (MSE) was 1.02 and RMSE 1.0, based on a 
20% validation sample selected randomly. The Pearson correlation was 0.66 with an actual coverage probability of 
the prediction interval as 94.3% based on nominal coverage at 95%.
Discussion
As progress is made on shrinking the malaria map51,52, the focus shifts to providing a strong evidence base to tar-
get vectors and parasites and maximise impact at the margins of malaria transmission. Malaria elimination is not 
only significant to health and economic development in vulnerable populations but also beneficial to other sec-
tors53–55. Here, we have outlined a methodological framework to support this goal using passive surveillance data 
from public and private health facilities to model malaria incidence seasonally and at a fine spatial resolution in 
low-endemic settings. By aggregating health facility data to operational administrative unit levels, while carrying 
Figure 3. Spatio-temporal maps of predicted mean monthly incidence of P. falciparum per 1000 
population in northern Namibia in areas with population density greater than 0.01 people per km2. The 
maps were created in ESRI ArcGIS 10.2 software (http://www.esri.com/software/arcgis/). Malaria incidence 
peaked in the December to April period and was lowest in May to October. The maps suggest less spatial 
variation between May and October. Accompanying uncertainty maps are included in the supplementary 
information. Data were from 29 months (from January 2012 to May 2014) based on confirmed malaria cases 
(n = 20,689 cases) from 322 health facilities in northern Namibia.
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Figure 4. (A) The modelled seasonal pattern of incidence of P. falciparum per 1000 population by month in 
22 northern districts in Namibia. Modelling results suggest that incidence varied by district and month, but 
was lowest between May and October. (B) Scatterplot showing the estimated mean population at risk of P. 
falciparum malaria in Namibia in 2014 and the Bayesian credible intervals based on predicted incidence by 
district and month. The credible intervals (Crl: Bayesian credible interval) were wider where the estimated mean 
population at risk was more than 10000 but closer to the mean where population at risk was < 10000. (C) The 
estimated population at risk of P. falciparum malaria in Namibia in 2014 by district and month. Population 
estimates are based on the worldpop dataset (http://www.worldpop.org.uk/) for Namibia. P. falciparum 
incidence estimates were modelled in a Bayesian framework from assembled malaria cases between 2012 and 
2014 and incorporating space-time covariates.
Region
Estimated 
population 2014
Estimated population count (%) at different malaria 
incidence
<0.5 0.5 to 1.0 >1.0
Zambezi 89,110 15,033 (16.9) 69,611 (78.1) 4,466 (5)
Kavango 188,279 42,216 (22.4) 86,051 (45.7) 60,012 (31.9)
Kunene 70,971 0 (0) 70,863 (99.8) 108 (0.2)
Ohangwena 272,544 111,928 (41.1) 143,536 (52.7) 17,079 (6.3)
Omaheke 104,389 37 (0.0) 104,352 (100) 0 (0)
Omusati 276,893 94,568 (34.2) 182,305 (65.8) 20 (0.0001)
Oshana 166,673 7,203 (4.3) 159,470 (95.7) 0 (0)
Oshikoto 184,969 1,154 (0.6) 171,485 (92.7) 12,330 (6.7)
Otjozondjupa 180,952 0 (0.0) 179,163 (99) 1,789 (1)
Total 1,534,781 271,719 (17.7) 1,168,524 (76.1) 94,537 (6.2)
Table 1.  Population count estimate by malaria incidence classification by region in the northern regions of 
Namibia. A map showing regions (place names in the table) is included in the supplementary information as Fig. 1).
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out predictions at fine spatial resolution, the methodology can be generalizable to other low transmission settings 
and to other infectious diseases. This improved mapping from passive surveillance data can help inform not only 
the spatial and temporal targeting of interventions, but also reactive case detection in low transmission settings. 
The demonstration in Namibia highlights the feasibility of the approach in producing accurate and spatially 
detailed incidence estimates over the course of a year that can be readily updated as new surveillance data are 
produced. The use of these maps by the NVDCP in Namibia for operational strategies already is testament to 
their value.
In general, the predicted incidence in our Namibia case study was low (average predicted incidence per 1000 
population for the 29 months period was less than 1.0). P. falciparum incidence in this period was anticipated 
to be lower than that predicted in 200918, owing to increased malaria control and interventions since 2009. In 
addition, an estimated 6.2% of the population lived in areas where case incidence was greater than 1.0 per 1000 
population and this was mainly in regions bordering Angola and Zambia in Kavango and Zambezi. It is possible 
that some of the malaria cases reported in these regions come from Angola or Zambia, or as a result of Namibians 
travelling to higher risk areas in these countries. Population movement remains a challenge for the NVDCP in 
Namibia23. An additional observation is that seasonal peaks of incidence occur early in the year coinciding with 
the rainy period in Namibia that runs from November to April56,57. Estimates from modelling suggested that 
risk remains in other regions in northern Namibia, although with a case incidence < 1.0 per 1000 in a sparsely 
distributed population. Aridity limits transmission along the Atlantic and the southern regions of Karas, Hardarp 
and Erongo in the Namib Desert and the Kalahari Desert (see Fig. 1 supplementary information for a map of 
Namibia showing these regions) while districts in zone 2 and zone 3 (Fig. 5 of supplementary information) sug-
gest focalised transmission could be targeted for elimination. Therefore, in terms of malaria control, such fine 
spatial resolution estimates of incidence could be useful in optimizing the delivery of interventions to specific 
areas in Kavango and Zambezi.
The NVDCP target the use of indoor residual spraying (IRS) using organochlorines Dichloro- 
diphenyl-trichloroethane (DDT) on traditional structures and deltamethrin (pyrethroid) on modern houses in 
Parameter Mean
Standard 
Deviation 5% Median 95%
Intercept ID − 1.0369 0.1600 − 1.3004 − 1.0369 − 0.7733
Ip − 1.5049 0.0620 − 1.9362 − 1.5047 − 1.0738
Precipitation β P1 − 0.0025 0.0202 − 0.0409 − 0.0025 0.0360
EVI β P2 − 0.0817 0.0275 − 0.1271 − 0.0817 0.0311
Precision for month τ t 0.8953 0.0908 0.2988 0.5456 3.0182
Precipitation β D1 0.1339 0.0145 0.1101 0.1339 0.1578
Spatial range rP 0.2470 0.0319 0.2005 0.2435 0.3048
rD 2.1118 0.4666 1.3440 2.1122 2.8869
Correlation Corr(P, D) 0.9353 0.0312 0.8848 0.9344 0.9882
Gaussian white noise σ ep2 1.4549 0.0244 1.4150 1.4545 1.4957
Spatial Variance vp 0.3145 0.0258 0.2750 0.3124 0.3610
vD 1.6665 0.0081 1.6530 1.6666 1.6799
Table 2.  Parameters of the fitted bivariate Bayesian spatial-temporal model of incidence using aggregated 
cases at district level and supported by space–time covariates. District level aggregated estimates of 
precipitation were used, but not for EVI where only 1 × 1 km mean estimates were used. Two intercepts were 
included in the bivariate model and spatial variance and spatial range parameters were also estimated.
Figure 5. Graphical representation of malaria incidence modelling framework. P is the output pixel level 
incidence at pixel level, η is the specification of linear predictor with spatial effects ν , covariate effects β , residual 
error σ e, and effect of the month (time) τ t.
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endemic regions in northern Namibia58. Recent findings suggest current IRS implementation suffers from sev-
eral problems including planning (number of structures, personnel), poor monitoring and evaluation, logistical 
(transportation, equipment, insecticide shortages), and operational (geographic reconnaissance)59. The current 
IRS implementation period in Namibia is between September and November. This study suggests priority dis-
tricts in zone one for targeted spraying, covering the Kavango and Zambezi regions (Fig. 5 supplementary), 
or blanket coverage in districts being targeted for elimination. Table 1 lists the population at risk applicable to 
planning of the IRS programme in each region. In addition, results here based on a combination of Figs 3 and 
4(a–c) suggest that IRS should ideally be implemented before the start of the transmission season, over a short 
time period, and covering the relevant geographic areas starting with zone one. Targeted IRS in the relevant 
geographic areas based on fine resolution maps should theoretically be more economical and sustainable while 
at same time maximising IRS impact on local vector species56,57. The same should be applied to targeted coverage 
of Long Lasting Insecticides Treated bednets (LLIN) in endemic areas. LLIN use in children under the age of five 
years was estimated at 34% nationally in 200945 when an estimated 0.5 million LLINs were distributed. Gueye et 
al.58 reported fluctuating coverage of LLINs in Ohangwena, Kunene and Omusati regions between 2009 and 2011 
where LLIN coverage reduced to 21% on average in the three regions. Between 2014 and 2015, just over 0.7 mil-
lion LLINs were distributed in these endemic regions based on funding from government and the Global Fund 
to fight AIDS, Tuberculosis and Malaria (GFATM), in order to fill that gap. The predicted incidence map show 
areas that should be targeted for LLIN coverage rather than universal coverage60 in Zambezi (Katima, Andara), 
Okavango (Nyangana, Rundu, Nankudu) and in Ohangwena (Kongo) to complement the IRS program.
Versions of the Bayesian modelling framework adopted here have been described and applied in other 
fields61–64 but not in modelling malaria incidence in very low transmission settings using passive surveillance 
data. Here, we addressed the previous challenges of using HMIS data14,65–67 by adjusting for health care utilisation 
in northern Namibia16, assumed a static denominator (population only projected forward on annual basis) and 
carried out predictions at a spatial resolution of 1 × 1 km using remotely sensed covariates linked to case data in 
space and time, while at same time estimating the uncertainty of prediction. A Bayesian model based approach 
takes into account the seasonal and environmental effects in adjusting for potential under-reporting as a result 
of fewer reported cases or missing data17. Using ecological and climatic covariates also helps in explained spatial 
variation at prediction stage in addition to providing information on the climatic suitability of malaria transmis-
sion41. While both public and private-based health facilities were used in the analysis, only a small fraction of 
the population in Namibia used the private sector68. The rates of health facility reporting were, however, not the 
100% required rate even in the regions with most malaria cases in our case study (Zambezi (88%), Ohangwena 
(90%), and Kavango (88%) as shown in the supplementary information). Reporting rate and classification of cases 
become important factors in the malaria elimination phase and during prevention of re-establishment10,69. The 
model set up relied on a valid spatial-cross covariance function with temporal innovations between aggregated 
input data and estimates at fine spatial resolution. It is also worth noting that the current improvements in case 
management in Namibia in which all suspected malaria fevers are diagnosed parasitologically before treatment 
eliminates the need for adjustment for test positivity rate. Diagnosis is based on Rapid Diagnostics Tests (RDT) 
and microscopy as recommended by WHO70,71, although information on number of slides examined is not avail-
able. These methods also suffer from uncertainties, for example, in terms of the quality of microscopy and RDTs 
being inefficient at detecting parasites at low density72,73. However, use of these case data provided a reliable 
indicator of the level of malaria incidence at fine spatial resolution, which is potentially useful in pre-elimination 
settings and not available otherwise.
In extending the methodology to different countries, the methodology outlined can be adapted to other 
malaria species such as P. vivax. Future approaches, however, should incorporate a higher temporally varying 
denominator74 and with spatially varying estimates of health care use within units of analysis. Other possible 
improvements may be to increase the number of spatially and temporally varying covariates and to assess the 
effects of static covariates on predictions. Modelling treatment-seeking behaviour can be improved in several 
ways: firstly, by incorporating uncertainty estimates in the denominator and propagating the quantified uncer-
tainty in estimates of the probability of fever treatment into the incidence modelling and, secondly, by integrating 
with population movement data to identify the effects of people moving across the border to seek treatment. The 
effect of population movements could also be combined with incidence maps to delineate self-sustaining trans-
mission foci from areas where transmission is supported by population movement.
In conclusion, one of the pillars for assessing the feasibility of malaria elimination is knowledge of the current 
level of transmission. Here, we demonstrated a method for predicting incidence at a fine spatial resolution for 
operational purposes in malaria elimination. As more countries transition to low-endemic malaria transmission 
status (below 5% parasite prevalence), fine spatial resolution mapping is important for identifying the sinks of 
transmission such as to target interventions. The method is also relevant to countries aiming to scale up interven-
tions, but which do not yet have the active surveillance capacity to adequately capture incidence and transmission 
burden. Mapping incidence at a fine spatial and temporal resolution improves clinical burden estimates and can 
be used to target resources to specific local populations. This remote targeting can be especially cost effective 
where the population distribution is sparse and further surveillance can be limited to specific local areas. The 
effect of population movements within country and internationally with neighbouring countries remains to be 
investigated as part of future research.
Methods
Bivariate model specification for incidence prediction. The goal was to estimate model parameters 
and carry out predictions of malaria incidence at fine spatial and temporal resolution. The general framework fol-
lowed a bivariate modelling framework with a misalignment between prediction and observed data. Here, a joint 
distribution of incidence at fine spatial resolution using a hierarchical Bayesian bivariate model for P. falciparum 
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was used with input data at coarse scales. Note that the methodology is different to univariate conditional autore-
gressive (CAR) modelling approach used previously for area-level prediction17,18. The joint framework adopted 
here relies on a linear combination of independent spatio-temporal processes to construct a valid set of spatial 
covariances and cross covariances61,63. Of interest in model parameter space was the correlation parameter related 
to the cross covariance specification between the data level and at a fine spatial prediction level. A bivariate 
approach allows for specification of likelihoods at different levels (for example the area-level i.e. the district, the 
pixel level at fine scale) as a change of support problem75,76 implemented in R-INLA77. Further details on R-INLA 
are in supplementary information. In brief, Gaussian Markov Random Fields (GMRFs) are used to represent the 
continuous domain Gaussian Random Field (GRF)78–80. The use of GMRFs has a computational advantage over 
the GRF representation popular with Markov Chain Monte Carlo (MCMC) algorithm due to the sparse nature 
of the resulting precision matrix of the GMRF representation80. For prediction, the interest was not only in esti-
mates (posterior means) at 1 × 1 km resolution, but also the variances or standard deviations associated with the 
predicted maps.
Starting with a generalized hierarchical regression model specification:
µ= + +z s t s t v s t e s t( , ) ( , ) ( , ) ( , ) (1)ij ij ij j
where zij(s, t) are realizations of the process for ith district and jth pixel, linked to a spatio-temporal structured 
predictor in an additive way, μij(s, t) arises from a set of local space-time covariates µ β=s t X s t( , ) ( , )ij ij
T
j (EVI 
and precipitation) with βj coefficients and ej(s, t) is the estimated measurement error e(s, t) ~ N(0, D) where D is a 
diagonal matrix τ=D jj j
2. vij(s, t) = Awij(s, t), with wij(s, t) arising from a zero mean Gaussian Matérn process with 
covariance cov{w(s, t), w(s′ , t′ )}≡ C(s, s′ ;t, t′ ). The specification of a white noise parameter is useful because vari-
ance in incidence is expected to change at fine spatial resolution. The model can be viewed in a hierarchical way 
with first level specification as z(s, t) ~ N(μ(s, t) + v(s, t)), D) and at a second-level, the joint distribution of v(s, t) 
≡ v(s1, t1), ....., v(sn, tj)' equivalent to MVNorm(0, Σ j).
Let the distribution of cases yi at the district level follow a Poisson distribution with expectation μi. That is:
µ µ~y EPoisson( exp{ }) (2)i
a
i i i
where Ei denotes the proportion of population at risk which is adjusted for a mean healthcare treatment rate and 
health system reporting rate. Thus, Ei = Rηi where R = reporting rate x utilisation rate and log(λi) = {β0i + β1iXi(s, 
t) + vi(s, t)} with spatial dependence modelled based on centroids of districts via Matérn covariance specification. 
Note that a CAR model specification could also be applied. The projected denominator population at risk is 
allowed to vary by year based on the UN population growth rate46, but not by month. The vectors of latent varia-
bles of the underlying counts = .....⁎ ⁎y y y( , , )i
a
i ip
T
1  are then assumed to follow ΣN (0, )i
a  distribution.
The second specification of responses was assumed to be Gaussian with
η σ~y N ( ) (3)j
b
j e,
2
where η α β= + + ∑ +β=v s t z e s t( , ) ( , )j j k
n
k kj1
 where α in the intercept, vj(s, t) is spatial field specification, on 
variable u, the βk are the coefficients for the covariates and e represents the residual error effects.
Given the above specification from equations 2 and 3, let =⁎y y y{( ) , ( ) }j j
a T
j
b T T denote vector of latent variables 
underlying response at location j. It is assumed that ⁎yj  follow a multivariate normal with block covariance matrix 
Σj
y81, generalised for bivariate specification as:
=







C h
C h C h
C h C h
( )
( ) ( )
( ) ( ) (4)
11 12
21 22
where h is a separation distance, Euclidean and
σ
σ
ρ σ σ
=
=
= =
C h M hv a
C h M hv a
C h C h M hv a
( ) ( , )
( ) ( , )
( ) ( ) ( , )
11 1
2
1 1
22 2
2
2 2
12 21 12 1 2 12 12
With C11(h) and C22(h) expressing the covariance of the two univariate processes and C12(h) the cross covariance, 
ρ12 is the correlation coefficient of the spatial process, with v and a parameters of the Matérn covariance (M) related 
to the smoothness and scaling respectively. The desired property of the cross covariance (Σ ) is that it is positive 
definite, that is, a'Σ a ≥ 0. The implementation in R-INLA use a stochastic partial differential equation (SPDE) 
representation with solution a GF with Matérn covariance is given by82 C(⋅ ) = σ2{2v−1Γ (v)}−1(a||h||)vkv(a||h||); 
where kv is the modified Bessel function of the second order kind and h is the Euclidean distance while σ2 is the 
marginal variance. a is the scaling parameter, with a 0, while ν is the Matérn smoothness parameter as defined 
above and is linked to the variance σ2 through α = ν + d/2 where d is the spatial dimension. α = 2 For d = 2 and 
v = 1. The marginal variance is then given by σ2 ≈ 1/4πk(s)2τ(s)2. The scaling parameter relates to the spatial range 
r of the model via r ≈ 8 /k(s) with an initial model approximation r = 1/5 of the spatial domain. Note that the 
parameters of SPDE are allowed to vary spatially thus the range parameter approximation is in the local context 
rather than a global range as it would apply in a stationary case.
The generalised model then takes the form,
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with β, σ, Σ parameters as explained in preceding sections with precipitation P and vegetation E as covariate 
effects.
The joint density of interest is given by;
∫ ∫θ ν µ Σ= Ω Ω ⁎ ⁎ ⁎ ⁎f y x dy dy( , ; ) ( ; ) (6)i i i i i i i1 2i i2 1
where Ω = −C C( , )i i y i y1 ,1, 1 ,1,i i1 1 , Ω = −C C( , )i i y i y2 ,2, 1 ,2,i i2 2 , and θ β β Σ=
⁎( , , )i i i1 2  denoting model parameters 
(Fig. 5 for full model parameters).
Bayesian specification is therefore completed by assigning prior distributions for βi ~ N(1, 100) 
(non-informative priors for intercepts and covariates), the parameters of the spatial-temporal fields were defined 
on the precision matrix of the SPDE defined as Q = T(K2CK2 + K2G + GK2 + GC−1G)T where T = diag(τ(s)) 
and K = diag(k(s)) with s defined as locations of GMRF representation. The internal representation in R-INLA 
requires prior specification on τ and k such that;
∑τ θ= +τ τ
=
s b s b slog( ( )) ( ) ( )
(7)k
N
k k0
1
∑ θ= +
=
k s b s b slog( ( )) ( ) ( )
(8)
k
k
N
k
k
k0
1
with τb s( )k  and b s( )k
k  were determined internally from spatial basis functions, while informative Gaussian priors 
set on θ following Ingebrigtsen et al.80. Thus, v ~ N(0, Q(k,τ)), log τ ~ N(0,1) for equation 7, log k ~ N(0,1) for 
equation 8 were used. The model likelihood was computed via the Newton-Raphson method83,84 where a 
log-likelihood function ℓ(θ; x) with θ as unknown parameters is maximised with Η (θ) as the matrix of the second 
derivative known as the Hessian matrix. For computational purposes, we checked and ensured that the Hessian 
was positive-definite (for convergence) by starting with a small h value parameter (h = 1e–10 and toler-
ance = 1e–20). Lastly, weakly informative inverse gamma priors were used for the white noise or residual error 
parameters D ~ IG(1, 1e–05).
Several statistical parameters were used to assess model fit predictive ability and how well the specified model 
fitted the data. A validation sample comprising of 20% of case reports (n = 70) of the dataset was selected ran-
domly and aggregated at district level. The remainder of the data were used as a training set to estimate model 
parameters. Firstly, model calibration (statistical consistency) and sharpness (concentration) were assessed 
using the probability integral transform (PIT) and the conditional predictive ordinate (CPO), a leave-one-out 
cross-validation approach in which an estimate is validated based on the fitted model and the remaining data 
only85,86. The PIT histogram should be a standard uniform distribution for a perfect model where the observed 
and predicted values are the same85. Secondly, estimates of the mean square error (MSE) that quantifies the 
discrepancy between observed and the predictions, the root mean square error (RMSE) which assess overall 
performance in the map, Pearson correlation and standardised residuals from the posterior mean were calcu-
lated. Pearson’s correlation coefficient was used to compare the predictions (district level after aggregation) to the 
observed values and scatter plots were produced.
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